Eyeonics Inc

Bausch & Lomb announced Sunday that the eye health company planned to acquire Eyeonics Inc., a privately held Aliso Viejo company that makes a lens used in cataract repair. Rochester-based Bausch & Lomb did not disclose financial terms. The transaction is expected to close in the first quarter. Once acquired, Eyeonics will be wrapped into Bausch & Lomb's surgical business, the company said. The U.S. surgical business will be led by J.

The authors of the Sarbanes-Oxley corporate reform law defended it Monday from criticism that it was hurting the country's capital markets. Former Sen. Paul S. Sarbanes (D-Md.), who wrote the law with former Rep. Michael G. Oxley (R-Ohio), said at an event in Washington to mark its fifth anniversary that it should not be amended. "Our goal was to restore investor confidence" after a wave of corporate scandals that began with the 2001 collapse of Enron Corp., Sarbanes said. "That's what we did."

Eyeonics Inc., a medical device company based in Aliso Viejo, filed a plan with regulators to sell as much as $86.3 million in stock in an initial public offering. Eyeonics makes lenses that can be implanted in the eye after the natural lens develops cataracts. The company says its crystalens model is the first lens approved by U.S. regulators that can correct presbyopia, which makes it hard for people in their 40s and older to see close-up objects. In the first half of 2006, Eyeonics had a $3.